SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford GlycoSciences Plc
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (273)12/27/2002 11:37:56 AM
From: scaram(o)uche   of 469
 
H&Q, Bear Stearns and SG Cowen were trying to get them out the door one year ago......

sec.gov

Under our current collaborations, we expect to screen approximately 240 different proteins. The table below summarizes our current collaborations: 

--------------------------------------------------------------------------------
 
Collaborator

   Effective date
of agreement

   Initial term

 

--------------------------------------------------------------------------------
 
Aventis   December 31, 2001   3 years 
Immusol   October 18, 2001   3 years 
Tularik   August 30, 2001   less than 1 year 
Schering-Plough   August 2, 2001   2 years 
Celltech   July 11, 2001   4.5 years 
Mitsubishi Pharma   July 4, 2001   1 year 
Biogen   June 29, 2001   39 months 
Oxford GlycoSciences   June 18, 2001   3 years 

--------------------------------------------------------------------------------


We know that the Mitsubishi collaboration has gone well.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News